Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SFDA To Issue Regulation On Technology Transfer Registrations

This article was originally published in PharmAsia News

Executive Summary

China's State FDA has finalized its policy on technology transfer registration for drugs, which it will issue this month. The regulation will encourage adoption and implementation of mature or advanced production technology, while reducing the number of approvals for new generics. In addition, approval and supervision of transferred drugs will be tightened and will forbid transfer application of high-risk drugs, suspend transfer of drugs with newly detected safety risks and reject transfer of drugs with risks found during technology reviews. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts